About
Oncology Treatments
Areas of Focus
Categories
Small Molecule PharmaceuticalBiotech
Clinical Trials (14)
View allTotal Trials
14
As Lead Sponsor
14
As Collaborator
0
Total Enrollment
1,424
By Phase
PHASE3: 2PHASE1/PHASE2: 4PHASE2: 2PHASE1: 5
By Status
RECRUITING: 4COMPLETED: 4WITHDRAWN: 2TERMINATED: 2ACTIVE_NOT_RECRUITING: 1AVAILABLE: 1
Clinical Trials Pipeline13 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
Today
Hover over trial bars to see details
Recent Trials
NCT07154706Lead Sponsor
Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)
PHASE3Recruiting
180 participants
Started: Aug 21, 2025 · Completed: Aug 30, 2033
NCT06564324Lead Sponsor
A Phase III Study Comparing Taletrectinib With Standard Therapy in ROS1 Positive Locally Advanced or Metastatic Non-small Cell Lung Cancer Patients
PHASE3Recruiting
138 participants
Started: Nov 27, 2024 · Completed: Sep 30, 2030
NCT06334432Lead Sponsor
Safety and Efficacy Study of NUV-1511 in Adult Patients With Advanced Solid Tumors
PHASE1/PHASE2Recruiting
466 participants
Started: Mar 14, 2024 · Completed: Oct 31, 2027
NCT05303519Lead Sponsor
Safusidenib Phase 2 Study in IDH1 Mutant Glioma
PHASE2Recruiting
125 participants
Started: Jun 5, 2023 · Completed: Mar 1, 2028
NCT05609929Lead Sponsor
Study the Effect of Omeprazole on AB-106 Pharmacokinetics
PHASE1Completed
24 participants
Started: Nov 2, 2022 · Completed: Jan 20, 2023
Locations (1)
Headquarters
San Francisco, CA, United States
Map
Loading map...